Literature DB >> 3099803

Metabolism of apolipoprotein C-I in normolipoproteinemic human subjects.

C L Malmendier, J F Lontie, G A Grutman, C Delcroix.   

Abstract

Labeling of apolipoprotein C-I by the Bolton and Hunter reagent allowed a study of the kinetics of this peptide in normolipidemic human volunteers. After its intravenous injection the appearance of radioactivity of the labeled apoprotein was followed in plasma, lipoprotein fractions, and urine for 15 days. Apolipoprotein C-I was quickly associated with HDL and to a smaller extent with VLDL in in vitro and in vivo incubation. Kinetic parameters of apolipoprotein C-I were compared with those of apo A-I. Fractional catabolic rates are respectively 0.422 +/- 0.044 vs 0.240 +/- 0.003 pools/day, residence times through the whole system 3.24 +/- 0.27 vs 6.31 +/- 0.27 days and production rates 1.79 +/- 0.18 vs 13.2 +/- 2.1 mg/kg X day. Two explanations for these differences are proposed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3099803     DOI: 10.1016/0021-9150(86)90063-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  2 in total

1.  Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma.

Authors:  Jean-Paul Pais de Barros; Aurélia Boualam; Thomas Gautier; Laure Dumont; Bruno Vergès; David Masson; Laurent Lagrost
Journal:  J Lipid Res       Date:  2009-05-05       Impact factor: 5.922

2.  Proteomic Analysis of Avian Influenza A (H7N9) Patients within a Family Cluster.

Authors:  Yang Zheng; Xiaomin Lou; Peng Yang; Weixian Shi; Yanda Chu; Meishuang Yan; Cuicui Jiang; Di Wu; Yang Pan; Jiachen Zhao; Yang Li; Yusheng Dong; Lijuan Chen; Siqi Liu; Quanyi Wang
Journal:  J Glob Infect Dis       Date:  2018 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.